US court backs Myriad to patent genes linked to cancer

May 2013

Highlights:

• BerGenBio's new approach to cancer target screening
• Supreme Court to hear Medtronic case
• Monsanto: Supreme Court rejects 'blame-the-bean' defence
• Self-collision of European patent filings

April 2013

Highlights:

• Novo Nordisk’s IP strategy
• OFT accuses GSK market abuse over pay-for-delay deals
• Actavis eyes $100 million after settlement
• Obviousness of DNA fragments in the post-Kubin era

March 2013

Highlights:

• India rejects Bayer plea over compulsory licence
• AstraZeneca settles Crestor patent dispute
• Twenty-one years of SPCs–a cause for celebration?
• Confidence in the face of counterfeits

February 2013

Highlights:

• Australian court backs Myriad in gene patent dispute
• B-MS loses Baraclude patent fight with Teva
• Hub and spoke? Life sciences in Northern France
• UK patent change paves way for pharma innovation